Cipro Buyers Urge Calif. Court To Revive Pay-For-Delay Case

Law360, New York (August 24, 2012, 7:29 PM EDT) -- A class of consumers on Thursday told California's highest court that Bayer AG's $400 million payout to end a rival's challenge to the patent for the antibiotic Cipro poses a threat to competition despite Bayer's claims that such pay-for-delay settlements aren't impeded by antitrust law.

In a reply brief in their appeal of a lower state court's decision dispensing with the class action, the Cipro consumers argued before the California Supreme Court that in spite of Bayer's contention that the state's antitrust law doesn't apply to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.